DOI: 10.1016/j.ajic.2017.06.010

,  

,  

PMID: 28757083

Issn Print: 0196-6553

Publication Date: 2018/01/01


Print

Underutilization of norovirus testing in hematopoietic cell transplant recipients at a large cancer center

Trenton J. MacAllister; Zach Stednick; Jonathan L. Golob; Meei-Li Huang; Steven A. Pergam

+ Author Information

Author Information: Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA

    loading  Checking for direct PDF access through Ovid

Abstract

The development of a new laboratory-developed norovirus assay provided an opportunity to assess testing patterns, incidence, and outcomes of norovirus among hematopoietic cell transplant (HCT) recipients. Clostridium difficile and norovirus tests from 1,393 HCT recipients were compared in these analyses. In this population of high-risk patients, norovirus appeared to occur seasonally, but testing was infrequent despite a correlation with more severe disease when compared with patients with C difficile infection.

    loading  Loading Related Articles